| Entry |
|
| Symbol |
PLCB2
|
| Name |
(RefSeq) 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2
|
| KO |
|
| Organism |
csyr Carlito syrichta (Philippine tarsier)
|
| Pathway |
| csyr04070 | Phosphatidylinositol signaling system |
| csyr04261 | Adrenergic signaling in cardiomyocytes |
| csyr04613 | Neutrophil extracellular trap formation |
| csyr04621 | NOD-like receptor signaling pathway |
| csyr04723 | Retrograde endocannabinoid signaling |
| csyr04750 | Inflammatory mediator regulation of TRP channels |
| csyr04925 | Aldosterone synthesis and secretion |
| csyr04928 | Parathyroid hormone synthesis, secretion and action |
| csyr04933 | AGE-RAGE signaling pathway in diabetic complications |
| csyr04935 | Growth hormone synthesis, secretion and action |
| csyr04961 | Endocrine and other factor-regulated calcium reabsorption |
| csyr04973 | Carbohydrate digestion and absorption |
| csyr05022 | Pathways of neurodegeneration - multiple diseases |
|
| Module |
| csyr_M00130 | Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3 => Ins(1,3,4,5)P4 |
|
| Brite |
KEGG Orthology (KO) [BR:csyr00001]
09100 Metabolism
09101 Carbohydrate metabolism
00562 Inositol phosphate metabolism
103272341 (PLCB2)
09130 Environmental Information Processing
09132 Signal transduction
04015 Rap1 signaling pathway
103272341 (PLCB2)
04310 Wnt signaling pathway
103272341 (PLCB2)
04371 Apelin signaling pathway
103272341 (PLCB2)
04020 Calcium signaling pathway
103272341 (PLCB2)
04070 Phosphatidylinositol signaling system
103272341 (PLCB2)
04072 Phospholipase D signaling pathway
103272341 (PLCB2)
04071 Sphingolipid signaling pathway
103272341 (PLCB2)
04022 cGMP-PKG signaling pathway
103272341 (PLCB2)
09133 Signaling molecules and interaction
04082 Neuroactive ligand signaling
103272341 (PLCB2)
04081 Hormone signaling
103272341 (PLCB2)
09140 Cellular Processes
09144 Cellular community - eukaryotes
04540 Gap junction
103272341 (PLCB2)
09150 Organismal Systems
09151 Immune system
04611 Platelet activation
103272341 (PLCB2)
04613 Neutrophil extracellular trap formation
103272341 (PLCB2)
04621 NOD-like receptor signaling pathway
103272341 (PLCB2)
04062 Chemokine signaling pathway
103272341 (PLCB2)
09152 Endocrine system
04911 Insulin secretion
103272341 (PLCB2)
04922 Glucagon signaling pathway
103272341 (PLCB2)
04929 GnRH secretion
103272341 (PLCB2)
04912 GnRH signaling pathway
103272341 (PLCB2)
04915 Estrogen signaling pathway
103272341 (PLCB2)
04921 Oxytocin signaling pathway
103272341 (PLCB2)
04926 Relaxin signaling pathway
103272341 (PLCB2)
04935 Growth hormone synthesis, secretion and action
103272341 (PLCB2)
04918 Thyroid hormone synthesis
103272341 (PLCB2)
04919 Thyroid hormone signaling pathway
103272341 (PLCB2)
04928 Parathyroid hormone synthesis, secretion and action
103272341 (PLCB2)
04916 Melanogenesis
103272341 (PLCB2)
04924 Renin secretion
103272341 (PLCB2)
04925 Aldosterone synthesis and secretion
103272341 (PLCB2)
04927 Cortisol synthesis and secretion
103272341 (PLCB2)
09153 Circulatory system
04261 Adrenergic signaling in cardiomyocytes
103272341 (PLCB2)
04270 Vascular smooth muscle contraction
103272341 (PLCB2)
09154 Digestive system
04970 Salivary secretion
103272341 (PLCB2)
04971 Gastric acid secretion
103272341 (PLCB2)
04972 Pancreatic secretion
103272341 (PLCB2)
04973 Carbohydrate digestion and absorption
103272341 (PLCB2)
09155 Excretory system
04961 Endocrine and other factor-regulated calcium reabsorption
103272341 (PLCB2)
09156 Nervous system
04724 Glutamatergic synapse
103272341 (PLCB2)
04725 Cholinergic synapse
103272341 (PLCB2)
04728 Dopaminergic synapse
103272341 (PLCB2)
04726 Serotonergic synapse
103272341 (PLCB2)
04720 Long-term potentiation
103272341 (PLCB2)
04730 Long-term depression
103272341 (PLCB2)
04723 Retrograde endocannabinoid signaling
103272341 (PLCB2)
09157 Sensory system
04742 Taste transduction
103272341 (PLCB2)
04750 Inflammatory mediator regulation of TRP channels
103272341 (PLCB2)
09159 Environmental adaptation
04713 Circadian entrainment
103272341 (PLCB2)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
103272341 (PLCB2)
09172 Infectious disease: viral
05163 Human cytomegalovirus infection
103272341 (PLCB2)
09174 Infectious disease: parasitic
05146 Amoebiasis
103272341 (PLCB2)
05142 Chagas disease
103272341 (PLCB2)
05143 African trypanosomiasis
103272341 (PLCB2)
09164 Neurodegenerative disease
05010 Alzheimer disease
103272341 (PLCB2)
05016 Huntington disease
103272341 (PLCB2)
05017 Spinocerebellar ataxia
103272341 (PLCB2)
05022 Pathways of neurodegeneration - multiple diseases
103272341 (PLCB2)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
103272341 (PLCB2)
05415 Diabetic cardiomyopathy
103272341 (PLCB2)
09167 Endocrine and metabolic disease
04933 AGE-RAGE signaling pathway in diabetic complications
103272341 (PLCB2)
04934 Cushing syndrome
103272341 (PLCB2)
09180 Brite Hierarchies
09182 Protein families: genetic information processing
04131 Membrane trafficking [BR:csyr04131]
103272341 (PLCB2)
Enzymes [BR:csyr01000]
3. Hydrolases
3.1 Acting on ester bonds
3.1.4 Phosphoric-diester hydrolases
3.1.4.11 phosphoinositide phospholipase C
103272341 (PLCB2)
Membrane trafficking [BR:csyr04131]
Exocytosis
Calcium ion-dependent exocytosis
Phospholipases
103272341 (PLCB2)
Endocytosis
Macropinocytosis
Phospholipase C
103272341 (PLCB2)
|
| SSDB |
|
| Motif |
|
| Other DBs |
|
| LinkDB |
|
| Position |
Unknown
|
| AA seq |
1081 aa
MSLLNPVLQPLKVKAYLSQGERFIKWDDETTMASPVILRVDSKGYYLYWTYQSKEMEFLD
ITNIRDTRFGKFAKMPKSQKLRDVFNMDFPDNNFLLKTLTVVSGPDMVDLTFHNFVSYKE
NVGKVWAEDVLALAKHPLATNAPRSTFLDKILVKLKMQLNPEGKIPVKNFFQMFPADRKR
VEAALSACHLPKGKNDAINPEDFPETVYKSFLMNLCARPEIDEIFTSYHSKAKPYMTKEH
LTKFINQKQRDSRLNSLLFPPARPDQVQGLIDKYEPSGINVQRGQLSPEGMVWFLCGPEN
SVLAQDKLLLHHDMTQPLNHYFINSSHNTYLTAGQFSGLSSAEMYRQVLLSGCRCVELDC
WKGKPPDEEPIITHGFTMTTDIFFKEAIEAIAESAFKTSPYPVILSFENHVDSPRQQAKM
AEYCRTIFGDMLLTEPLEKFPLNPGVPLPSPEDLKGKILIKNKKNQFSGPAATSKEAVGE
AEGSCTLSAPAGEDTVWAGEEGTELEEEEVEEEEEEESGSLDEEEIKKMQSDEGTAGLEV
TAYEEMSSLVNYIQPTKFISFEFSAQKNRSYVISSFTELKAYDLLSKASVQFVDYNKRQM
SRIYPKGTRMDSSNYMPQMFWNAGCQMVALNFQTMDLPMQQNMALFEFNGQTGYLLKHEF
MRRPDKQFNPFSVDRIDVVVATTLSITVISGQFLSERSVRTCVEVELFGLPGDPKRRYRT
KLSPSTNSINPVWKEEPFVFEKILMPELASLRVVVMEEGNKFLGHRIIPINALNSGYHHL
CLHSESNMPLTMPALFVFLEMKDYVPDTWADLTVALANPIKFFNAHDKKSVKLKEAMGGP
PEKPFPLSSPVTSQVNGASAPTSNGSAAAGARAREEAIREAAEPRTASLEELRELKGVAK
LQRRHEKELVNKVMELAREKQAAELKTLKETLESDTKEMKKKLEAKRLERIQAMTKVTID
KMAQERLKREINNSHIQEVVQVIKQITENLEKHQEKLEEKQAACLEQIREMEKQFQQEAM
EEYEGKMRGLESEVKESVRACLRTCFPSEAEDKPEGAWEAPREPCEQDTPTAKADAQESR
L |
| NT seq |
3246 nt +upstreamnt +downstreamnt
atgtctctgctcaaccctgtcctgcagcccctcaaggtgaaggcctatttgagccaaggg
gaacgcttcatcaaatgggacgatgaaactacaatggcctcccctgttattcttcgtgtg
gattccaagggctattatttatactggacataccagagtaaggagatggagtttctggat
atcaccaacatccgagacactcgctttgggaagtttgccaagatgcccaagagccagaag
ctccgggatgttttcaacatggactttcctgacaacaacttcctgctgaagacactcacg
gtggtgtctggccccgacatggtggacctcaccttccacaactttgtctcctacaaagag
aacgtgggcaaggtctgggctgaggatgtactggccctggccaagcacccgctggccacc
aatgccccccgcagcaccttcctggacaagatcttagtgaagctcaagatgcaactcaac
cctgaagggaagattccggtgaagaattttttccagatgtttcctgctgatcgtaagcgg
gtggaagctgctctcagtgcctgccatcttccaaaaggcaagaatgatgccatcaatcct
gaagacttcccagaaaccgtctacaagagtttcctcatgaacctctgtgcccggccagaa
atagatgagatcttcacttcctatcattctaaggccaaaccctacatgactaaggagcac
ctgaccaaattcatcaaccagaaacagcgggactcccgactgaactccctgttgttcccg
ccagcccggcctgaccaggtgcagggcctcattgacaagtatgagcccagtggcatcaac
gtgcagaggggccagctgtcacccgagggcatggtttggtttctctgtgggccagagaac
agcgtgctggcccaggacaagctgctgctccaccacgacatgacacagccactcaatcat
tatttcatcaattcctctcacaatacttacctgacagctggccagttctcaggcctttcc
tcggctgagatgtaccgccaggtgctgctgtctggctgccgttgtgtggagctagactgc
tggaaagggaagccccctgatgaggagcccattatcacccacggcttcaccatgaccaca
gacatctttttcaaggaagcaatcgaggctattgcagaaagtgcttttaagacctccccc
tatcccgtcatcctgtcgtttgagaatcacgtggactcaccccgccaacaggctaagatg
gctgagtattgccggacgatctttggggatatgctgctcacagagcccctggaaaagttc
ccactgaatccaggagtccccctacccagccctgaggatctcaagggcaaaatcctcatc
aagaacaagaagaatcagttttctggcccggcagccaccagtaaggaagctgtcggggag
gctgagggcagctgcaccctcagtgcccctgcaggcgaggacacagtgtgggctggcgag
gaagggactgagctggaggaggaggaggtggaagaggaagaggaggaggagtcgggaagc
ctggatgaagaagagattaagaagatgcagtcagatgagggcacagcgggcctggaggtg
acggcttacgaggagatgtccagcctagtcaattacatccagcccaccaagttcatctcc
tttgagttctctgcccagaagaaccgaagttatgtcatctcctccttcacggagctcaag
gcttatgacctgctctccaaggcctcagtgcagtttgtggactacaacaagcgccagatg
agccgcatttaccccaagggaacccgcatggactcctccaactacatgccccagatgttc
tggaatgctggatgccagatggttgccctcaatttccagacaatggacctgcccatgcag
cagaacatggcgctgtttgagttcaatgggcagacgggctacctcctgaaacacgagttc
atgcgccggccggacaagcagttcaaccctttctcagtggaccgcatcgacgtggtggta
gccaccaccctttccattacggtgatctctgggcagttcctatcagaacgcagtgtgcgc
acctgtgtggaagtggagttgtttggccttcctggggaccccaagaggcgctatcgtacc
aagctgtcacctagcaccaactctatcaatcctgtctggaaggaggagccctttgtcttt
gagaagatcttgatgcctgagctggcctccctcagggtggttgtgatggaagaaggcaac
aaatttcttggacaccgaatcatccccattaatgccctgaattctgggtaccatcatctg
tgcctgcacagcgagagcaacatgcccctcacgatgcctgcgctcttcgtcttcctggag
atgaaggactatgtacccgacacctgggcagatctcactgtggctcttgccaaccccatc
aagttcttcaatgcccacgacaagaagtctgtgaagctcaaggaagccatgggaggtccc
cctgagaagcccttcccactcagcagtccagtcaccagccaggtcaatggggcatcggct
ccaacgagcaatggatcggcagcagccggggccagggccagagaggaggccataagagaa
gccgcggagccgcggaccgccagcctggaggagcttcgggagctgaagggcgtcgcgaag
ctgcagcggcggcacgagaaggagctagtcaacaaggtgatggagctggcccgagagaag
caggcggcagagctgaagaccctcaaggagacgttggagagtgacaccaaagagatgaag
aaaaagctggaggccaagaggctggagcggatccaggccatgaccaaagtcaccatagac
aagatggcccaggagaggttaaagagagagattaataactcccacatccaggaagtggtg
caggtcatcaagcagatcacagagaatctggagaagcatcaggagaagctagaggagaag
caggcagcctgcctggaacagatccgggagatggaaaagcagttccagcaggaggcgatg
gaagagtacgaaggcaagatgaggggtctggagtccgaggtgaaggagtcggtgagggcc
tgcctcaggacctgcttcccttccgaggccgaggacaagcctgagggggcctgggaggcc
cccagggagccatgtgagcaggacacaccgacagcaaaggctgacgcccaggagagccgc
ctctga |